Topotecan (Hycamptin) was approved by the FDA for the treatment of metastatic ovarian cancer
On Jul. 1, 1996, topotecan (Hycamptin), the first of a class of drugs that interferes with the enzyme…
The Federal Tea Tasters Repeal Act was passed
On Apr. 9, 1996, the Federal Tea Tasters Repeal Act of 1996 eliminated the Board of Tea Experts…
Diagnostics | FDA | HIV
The FDA approved the first test for HIV antigen screening of blood donors
On Mar. 14, 1996, the U.S. Food and Drug Administration (FDA) announced the approval of the first antigen…
Biotechnology | Diagnostics | Disease | FDA | Medical Device | Therapeutics
GeneChip was developed by Stanford University and Affymetrix
On Dec. 11, 1996, scientists from Stanford University and Affymetrix announced a new high-tech method that used a…
The first genetically engineered crop was commercialized
In 1996, the first genetically engineered crop was commercialized. The first genetically modified plant was produced a short…
Biotechnology | Diagnostics | Disease | FDA | Oncology
The FDA approved another topoisomerase 1 inhibitor for the treatment of metastatic colorectal cancer
In June 1996, the Food and Drug Administration (FDA) first approved irinotecan for the treatment of patients with…
Biotechnology | Disease | FDA | Therapeutics
Genentech drug Nutropin AQ ((somatropin) injection for subcutaneous use) was approved
On Dec. 29, 1995, the Genentech drug Nutropin AQ ((somatropin) injection for subcutaneous use) was approved by the…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
The FDA approved anastrozole (Arimidex) as a treatment for breast cancer
Dec. 27, 1995, the U.S. Food and Drug Administration (FDA) approved anastrozole (Arimidex) as a treatment for breast…
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved tretinoin, a differentiating agent related to vitamin A, for use in the treatment of acute promyelocytic leukemia
On Dec. 9, 1995, the U.S. Food and Drug Administration (FDA) approved tretinoin, a differentiating agent related to…
Biotechnology | Diagnostics | FDA | Oncology | U.S. Congress
Saccharin Notice Repeal Act repealed the saccharin notice requirements
On Dec. 6, 1995, the U.S. Congress repealed the saccharin notice requirements. The store warning notice requirement was…
Porfimer sodium, a light-sensitive drug that can be absorbed by tumors, was approved by the FDA
In 1995, Porfimer sodium, a light-sensitive drug that can be absorbed by tumors, was approved by the U.S. Food…
Proposed reforms to reduce regulatory burden on pharmaceutical manufacturers were announced
On Sept. 27, 1995, a series of proposed reforms to reduce regulatory burden on pharmaceutical manufacturers were announced….
Genentech drug CellCept (mycophenolate mofetil) approved by FDA
On May 3, 1995, the U.S. Food & Drug Administration (FDA) announced it had approved Genentech’s drug CellCept…
FDA declared cigarettes to be “drug delivery devices”
In 1995, the FDA declared cigarettes to be “drug delivery devices.” Restrictions were proposed on marketing and sales…
Biotechnology | CDC | FDA | Infectious Disease | Influenza | Measles | Polio | Vaccine
The ACIP, American Academy of Pediatrics, and the American Association of Family Physicians issued the first “harmonized” childhood immunization schedule
In 1995, the Immunization Practices Advisory Committee (ACIP), American Academy of Pediatrics, and the American Association of Family…
The FDA approved the first US HIV test system using oral fluid samples
On Dec. 23, 1994, the FDA announced the approval of the first U.S. HIV test system using oral…
Dietary Supplement Health and Education Act established specific labeling requirements for dietary supplements
On Oct. 25. 1994, the Dietary Supplement Health and Education Act was enacted establishing specific labeling requirements, provided…
Animal Medicinal Drug Use Clarification Act allowed veterinarians to prescribe extra-label use of veterinary drugs
On Oct. 22, 1994, the Animal Medicinal Drug Use Clarification Act (AMDUCA) became law permitting veterinarians to prescribe…
The FDA approved the first genetically modified food: the “Flavr Savr” tomato
On May 17, 1994, the U.S. Food and Drug Administration (FDA) approved of the first genetically modified food:…
FDA | Oncology | U.S. Congress
FDA announced it could consider regulating nicotine in cigarettes as a drug
On Feb. 25, 1994, the U.S. Food and Drug Administration (FDA) announced it could consider regulating regulating tobacco…
Biotechnology | Diagnostics | Disease | FDA | Neurology | Ophthalmogy
Omeros Corp was founded
In 1994, Omeros Corp. was founded in Seattle as a biopharmaceutical company committed to discovering, developing and commercializing…
Bristol-Myers Squibb’s PRAVACHOL (pravastatin sodium) granted expanded usage from the FDA
In 1994, Bristol-Myers Squibb’s PRAVACHOL (pravastatin sodium) was granted expanded usage from the U.S. Food and Drug Administration…
Rimantadine was approved by the FDA to treat influenza A
In 1994, Rimantadine, derived from amantadine, was approved by the Food and Drug Administration (FDA) to treat influenza…
Biotechnology | Disease | FDA | Medicine
Genentech drug Pulmozyme (dornase alfa) was approved by the FDA
On Dec. 30, 1993, the Genentech drug Pulmozyme (dornase alfa) was approved by the U.S. Food and Drug…
Biotechnology | FDA | Medicine | Therapeutics
FDA approved Risperidone for use as atypical antipsychotic medication
On Dec. 29, 1993, the U.S. Food and Drug Administration (FDA) approved indications for oral risperidone (tablets, oral…
Genentech drug Nutropin was approved
On Nov. 17, 1993, Genentech drug Nutropin was approved by the U.S. Food and Drug Administration (FDA) for…
FDA granted approval for the sale of the Ahmed Glaucoma Valve
On Nov. 12 ,1993, FDA granted approval for the sale of the Ahmed Glaucoma Valve designed and manufactured…
Biotechnology | Disease | FDA | Therapeutics
FDA approved Betaseron, the first of several biotech products that have had a major impact on multiple sclerosis treatment
On Jul. 23, 1993, the U.S. Food and Drug Administration (FDA) approved Bayer’s Betaseron, the first of several…
Clinical Research | Disease | FDA | IRB | Medicine | Oncology | Therapeutics | Women's Health
FDA issued guidelines calling for improved assessments of medication responses as a function of gender
On Jul. 22, 1993, revising a policy from 1977 that excluded women of childbearing potential from early drug…
Biotechnology | Chemical | Disease | FDA | Therapeutics
The Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established
On Apr. 14, 1993, the Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established…